Alex G. Richter

University of Birmingham - Institute of Cancer and Genomic Sciences

Edgbaston

Birminham, Birmingham B152TT

United Kingdom

University of Birmingham - Clinical Immunology Service

Birmingham

United Kingdom

SCHOLARLY PAPERS

13

DOWNLOADS
Rank 3,350

SSRN RANKINGS

Top 3,350

in Total Papers Downloads

15,837

SSRN CITATIONS

8

CROSSREF CITATIONS

4

Scholarly Papers (13)

1.

Examining the Immunological Effects of COVID-19 Vaccination in Patients with Conditions Potentially Leading to Diminished Immune Response Capacity – The OCTAVE Trial

Number of pages: 25 Posted: 23 Aug 2021
University of Birmingham - NIHR Birmingham Biomedical Research Centre and Institute of Cancer and Genomic Sciences, University of Glasgow, Imperial College London, University of Birmingham, University of Birmingham, University of Birmingham, University of Birmingham, University of Birmingham, University of Birmingham, University of Oxford, University of Oxford, University of Oxford, University of Oxford, University of Oxford, University of Oxford, University of Oxford, University of Birmingham - Institute of Cancer and Genomic Sciences, Imperial College London, University of Oxford, NHS Foundation Trust - St. Georges University Hospitals, University Hospitals Birmingham NHS Foundation Trust, University of Leeds, University of Liverpool - NIHR Health Protection Research Unit in Emerging and Zoonotic Infections, University of Oxford - Peter Medawar Building for Pathogen Research, University of Oxford - Peter Medawar Building for Pathogen Research, University of Glasgow - Institute of Infection, Immunity and Inflammation, University of Sheffield - Department of Infection, Immunity & Cardiovascular Disease, Imperial College London, Oxford University Hospitals NHS Foundation Trust, University of Glasgow and University of Glasgow
Downloads 4,554 (2,907)

Abstract:

Loading...

2.

Single Vaccination with BNT162b2 or ChAdOx1 in Older People Induces Equivalent Antibody Generation but Enhanced Cellular Responses after ChAdOx1

Number of pages: 15 Posted: 13 Apr 2021
University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Cancer and Genomic Sciences, University Hospitals Birmingham NHS Foundation Trust, Harborne Medical Practice, Public Health England, Public Health England - Immunisation and Countermeasures Division, Public Health England - National Infection Service, University of Birmingham - Institute of Cancer and Genomic Sciences and University of Birmingham - Institute of Immunology and Immunotherapy
Downloads 4,394 (3,097)
Citation 10

Abstract:

Loading...

Vaccination, SARS-CoV-2, COVID, Antibody, Cellular, mRNA, ChAdOx1

T-Cell and Antibody Responses to First BNT162b2 Vaccine Dose in Previously SARS-CoV-2-Infected and Infection-Naive UK Healthcare Workers: A Multicentre, Prospective, Observational Cohort Study

Number of pages: 55 Posted: 25 Mar 2021
University of Sheffield - Department of Infection, Immunity & Cardiovascular Disease, University of Oxford - Wellcome Trust Centre for Human Genetics, University of Liverpool - NIHR Health Protection Research Unit in Emerging and Zoonotic Infections, Newcastle University - Translational and Clinical Research Institute Immunity and Inflammation Theme, University of Oxford - Sir William Dunn School of Pathology, University of Oxford - Wellcome Trust Centre for Human Genetics, University of Oxford - Peter Medawar Building for Pathogen Research, University of Oxford - Peter Medawar Building for Pathogen Research, University of Liverpool - NIHR Health Protection Research Unit in Emerging and Zoonotic Infections, Sheffield Teaching Hospitals NHS Foundation Trust, University of Liverpool - HPRU in Emerging and Zoonotic Infections, University of Sheffield - Department of Infection, Immunity & Cardiovascular Disease, Oxford University Hospitals NHS Foundation TrustUniversity of Oxford - Nuffield Department of Clinical Neurosciences, Public Health England Colindale, University of Liverpool - NIHR Health Protection Research Unit in Emerging and Zoonotic Infections, University of Liverpool - Institute of Infection, Veterinary and Ecological Sciences, University of Sheffield - Department of Infection, Immunity & Cardiovascular Disease, University of Sheffield - Department of Infection, Immunity & Cardiovascular Disease, Newcastle University - Translational and Clinical Research Institute Immunity and Inflammation Theme, Newcastle University - Translational and Clinical Research Institute Immunity and Inflammation Theme, Newcastle University - Translational and Clinical Research Institute, University of Oxford - Peter Medawar Building for Pathogen Research, University of Sheffield - Department of Infection, Immunity & Cardiovascular Disease, Sheffield Teaching Hospitals NHS Foundation Trust, Oxford University Hospitals NHS Foundation Trust, Oxford University Hospitals NHS Foundation Trust, University of Oxford - Department of Paediatrics, University of Oxford - Peter Medawar Building for Pathogen Research, University of Oxford - Oxford Vaccine Group, University of Oxford - Peter Medawar Building for Pathogen Research, University of Oxford - Peter Medawar Building for Pathogen Research, University of Oxford - Peter Medawar Building for Pathogen Research, University of Oxford - Peter Medawar Building for Pathogen Research, University of Oxford - Peter Medawar Building for Pathogen Research, University of Oxford - Peter Medawar Building for Pathogen Research, Public Health England Colindale, University of Birmingham - Institute of Cancer and Genomic Sciences, University of Oxford - Peter Medawar Building for Pathogen Research, University of Oxford - NIHR Health Protection Research Unit in Healthcare Associated Infection and Antimicrobial Resistance, Public Health England Colindale, University of Oxford - Sir William Dunn School of Pathology, University of Sheffield - Department of Infection, Immunity & Cardiovascular Disease, University of Oxford - Peter Medawar Building for Pathogen Research, University of Oxford - Peter Medawar Building for Pathogen Research, University of Birmingham - Institute of Cancer and Genomic Sciences, Newcastle upon Tyne Hospitals NHS Foundation Trust - Department of Infection and Tropical Medicine, Oxford University Hospitals NHS Foundation Trust, University of Oxford - Wellcome Centre for Human Genetics, University of Liverpool - NIHR Health Protection Research Unit in Emerging and Zoonotic Infections, University of Sheffield - Department of Infection, Immunity & Cardiovascular Disease and Independent
Downloads 3,657 (4,103)
Citation 12

Abstract:

Loading...

T-Cell and Antibody Responses to First BNT162b2 Vaccine Dose in Previously SARS-CoV-2-Infected and Infection-Naive UK Healthcare Workers: A Multicentre, Prospective, Observational Cohort Study

Number of pages: 55 Posted: 13 Apr 2021
University of Sheffield - Department of Infection, Immunity & Cardiovascular Disease, University of Oxford - Wellcome Trust Centre for Human Genetics, University of Liverpool - NIHR Health Protection Research Unit in Emerging and Zoonotic Infections, Newcastle University - Translational and Clinical Research Institute Immunity and Inflammation Theme, University of Oxford - Sir William Dunn School of Pathology, University of Oxford - Wellcome Trust Centre for Human Genetics, University of Oxford - Peter Medawar Building for Pathogen Research, University of Liverpool - NIHR Health Protection Research Unit in Emerging and Zoonotic Infections, Sheffield Teaching Hospitals NHS Foundation Trust, Oxford University Hospitals NHS Foundation TrustUniversity of Oxford - Nuffield Department of Clinical Neurosciences, Public Health England Colindale, University of Liverpool - NIHR Health Protection Research Unit in Emerging and Zoonotic Infections, University of Liverpool - Institute of Infection, Veterinary and Ecological Sciences, University of Sheffield - Department of Infection, Immunity & Cardiovascular Disease, University of Sheffield - Department of Infection, Immunity & Cardiovascular Disease, Newcastle University - Translational and Clinical Research Institute Immunity and Inflammation Theme, Newcastle University - Translational and Clinical Research Institute Immunity and Inflammation Theme, Newcastle University - Translational and Clinical Research Institute, University of Oxford - Peter Medawar Building for Pathogen Research, University of Sheffield - Department of Infection, Immunity & Cardiovascular Disease, Sheffield Teaching Hospitals NHS Foundation Trust, Oxford University Hospitals NHS Foundation Trust, Oxford University Hospitals NHS Foundation Trust, University of Oxford - Department of Paediatrics, University of Oxford - Peter Medawar Building for Pathogen Research, University of Oxford - Oxford Vaccine Group, University of Oxford - Peter Medawar Building for Pathogen Research, University of Oxford - Peter Medawar Building for Pathogen Research, University of Oxford - Peter Medawar Building for Pathogen Research, University of Oxford - Peter Medawar Building for Pathogen Research, University of Oxford - Peter Medawar Building for Pathogen Research, University of Oxford - Peter Medawar Building for Pathogen Research, Public Health England Colindale, University of Birmingham - Institute of Cancer and Genomic Sciences, University of Oxford - Peter Medawar Building for Pathogen Research, University of Oxford - NIHR Health Protection Research Unit in Healthcare Associated Infection and Antimicrobial Resistance, Public Health England Colindale, University of Oxford - Sir William Dunn School of Pathology, University of Sheffield - Department of Infection, Immunity & Cardiovascular Disease, University of Oxford - Peter Medawar Building for Pathogen Research, University of Oxford - Peter Medawar Building for Pathogen Research, University of Birmingham - Institute of Cancer and Genomic Sciences, Newcastle upon Tyne Hospitals NHS Foundation Trust - Department of Infection and Tropical Medicine, Oxford University Hospitals NHS Foundation Trust, University of Oxford - Wellcome Centre for Human Genetics, University of Liverpool - NIHR Health Protection Research Unit in Emerging and Zoonotic Infections, University of Sheffield - Department of Infection, Immunity & Cardiovascular Disease and Independent
Downloads 492 (81,036)
Citation 12

Abstract:

Loading...

4.

BNT162b2 Vaccination in People Over 80 Years of Age Induces Strong Humoral Immune Responses with Cross Neutralisation of P.1 Brazilian Variant

Number of pages: 24 Posted: 31 Mar 2021
University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Cancer and Genomic Sciences, University of Birmingham - Institute of Immunology and Immunotherapy, Quinton and Harborne PCN, University of Birmingham - Institute of Immunology and Immunotherapy, Deparment of Buisness Energy and Industrial Strategy - Vaccine Taskforce, Public Health England, Public Health England - Immunisation and Countermeasures Division, Public Health England - National Infection Service, Government of the United Kingdom - National Infection Service, Government of the United Kingdom - National Infection Service, Government of the United Kingdom - National Infection Service, Government of the United Kingdom - National Infection Service, Government of the United Kingdom - National Infection Service, Public Health England, UK Health Security Agency, Government of the United Kingdom - National Infection Service, Government of the United Kingdom - National Infection Service, Public Health England - National Infection Service, Oxford Immunotec LTD, University of Birmingham - Institute of Cancer and Genomic Sciences and University of Birmingham - Institute of Immunology and Immunotherapy
Downloads 1,220 (24,193)

Abstract:

Loading...

Vaccination. SARS-CoV-2. COVID. Immunosenescence. Antibody. T-cell. Variant. Neutralisation. Ageing. Immunisation

5.

Antibody Responses After First and Second COVID-19 Vaccination in Patients With Chronic Lymphocytic Leukaemia

Number of pages: 23 Posted: 25 May 2021
University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Cancer and Genomic Sciences, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Applied Health Research, UK Health Security Agency, University of Birmingham - Cancer Research UK Clinical Trials Unit, University of Birmingham - Cancer Research UK Clinical Trials Unit, University of Birmingham - Institute of Cancer and Genomic Sciences, University of Birmingham - Institute of Immunology and Immunotherapy, Leeds Teaching Hospitals NHS Trust - St. James’s University Hospital, University Hospitals Birmingham - Queen Elizabeth Hospital, University Hospitals Birmingham - Birmingham Heartlands Hospital, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Cancer and Genomic Sciences and University of Birmingham - Institute of Immunology and Immunotherapy
Downloads 955 (34,360)
Citation 3

Abstract:

Loading...

Vaccination; CLL; Leukaemia; SARS-CoV-2; COVID; Antibody

6.

Sustained T Cell Immunity, Protection and Boosting Using Extended Dosing Intervals of BNT162b2 mRNA Vaccine

Number of pages: 93 Posted: 21 Jul 2021
Newcastle University - Translational and Clinical Research Institute Immunity and Inflammation Theme, University of Oxford - Wellcome Trust Centre for Human Genetics, University of Liverpool - NIHR Health Protection Research Unit in Emerging and Zoonotic Infections, Oxford University Hospitals NHS Foundation TrustUniversity of Oxford - Nuffield Department of Clinical Neurosciences, University of Oxford - Wellcome Centre for Human Genetics, University of Oxford - Peter Medawar Building for Pathogen Research, Sheffield Teaching Hospitals NHS Foundation Trust, University of Birmingham - Institute of Cancer and Genomic Sciences, University of Birmingham - Institute of Cancer and Genomic Science, University of Liverpool - NIHR Health Protection Research Unit in Emerging and Zoonotic Infections, University of Oxford - Wellcome Trust Centre for Human Genetics, University of Liverpool - NIHR Health Protection Research Unit in Emerging and Zoonotic Infections, University of Sheffield - Department of Infection, Immunity & Cardiovascular Disease, University of Sheffield - Department of Infection, Immunity and Cardiovascular Disease, Public Health England Colindale, University of Liverpool - NIHR Health Protection Research Unit in Emerging and Zoonotic Infections, Oxford University Hospitals NHS Foundation Trust, University of Oxford - Wellcome Centre for Human Genetics, Newcastle University - Translational and Clinical Research Institute Immunity and Inflammation Theme, University of Sheffield - Department of Infection, Immunity & Cardiovascular Disease, University of Sheffield - Department of Infection, Immunity & Cardiovascular Disease, Newcastle University - Translational and Clinical Research Institute Immunity and Inflammation Theme, Newcastle University - Translational and Clinical Research Institute Immunity and Inflammation Theme, Newcastle University - Translational and Clinical Research Institute Immunity and Inflammation Theme, University of Sheffield - Department of Infection, Immunity & Cardiovascular Disease, Sheffield Teaching Hospitals NHS Foundation Trust, University of Oxford - Peter Medawar Building for Pathogen Research, University of Oxford - Peter Medawar Building for Pathogen Research, University of Oxford, University Hospitals Birmingham NHS Foundation Trust, Public Health England Colindale, Public Health England Colindale, Oxford University Hospitals NHS Foundation Trust, University of Oxford - Peter Medawar Building for Pathogen Research, University of Liverpool - Institute of Infection, Veterinary and Ecological Sciences, Oxford University Hospitals NHS Foundation Trust, Oxford University Hospitals NHS Foundation Trust, University of Oxford - Peter Medawar Building for Pathogen Research, University of Oxford - Peter Medawar Building for Pathogen Research, University of Oxford - Peter Medawar Building for Pathogen Research, University of Oxford - Oxford Vaccine Group, University of Oxford - Centre for Vaccinology and Tropical Medicine, University of Oxford - Peter Medawar Building for Pathogen Research, Sheffield Teaching Hospitals NHS Foundation Trust, University of Oxford - Wellcome Trust Centre for Human Genetics, Oxford University Hospitals NHS Foundation Trust, University of Oxford - NIHR Health Protection Research Unit in Healthcare Associated Infection and Antimicrobial Resistance, Public Health England Colindale, Newcastle upon Tyne Hospitals NHS Foundation Trust - Department of Infection and Tropical Medicine, University of Birmingham - Institute of Cancer and Genomic Sciences, University of Oxford - Wellcome Centre for Human Genetics, University of Oxford - Wellcome Centre for Human Genetics, University of Sheffield - Department of Infection, Immunity & Cardiovascular Disease, University of Liverpool - NIHR Health Protection Research Unit in Emerging and Zoonotic Infections, University of Oxford - Peter Medawar Building for Pathogen Research, University of Oxford - Peter Medawar Building for Pathogen Research and Independent
Downloads 156 (261,816)
Citation 6

Abstract:

Loading...

7.

Impaired Neutralisation of SARS-CoV-2 Delta Variant in Vaccinated Patients With B Cell Chronic Lymphocytic Leukaemia

Number of pages: 26 Posted: 12 Oct 2021
University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Cancer and Genomic Sciences, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham, University of Glasgow, University of Glasgow - Centre for Virus Research (CVR), University of Glasgow, University of Glasgow - Centre for Virus Research (CVR), University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham, UK Health Security Agency, University of Birmingham - Cancer Research UK Clinical Trials Unit, University of Birmingham - Cancer Research UK Clinical Trials Unit, University of Birmingham - Institute of Cancer and Genomic Sciences, University of Birmingham - Institute of Cancer and Genomic Sciences, Government of the United Kingdom - Royal Wolverhampton NHS Trust, Barking, Havering and Redbridge University Hospitals NHS Trust - Sandwell and West Birmingham Hospitals NHS Trust, Herefordshire and Worcestershire Health and Care NHS Trust, Government of the United Kingdom - University Hospitals Birmingham, University Hospitals Birmingham - Birmingham Heartlands Hospital and University of Birmingham - Institute of Immunology and Immunotherapy
Downloads 151 (268,698)

Abstract:

Loading...

CLL, COVID-19, SARS-CoV-2, Vaccination

8.

Poor Antibody Responses to SARS-CoV-2 Infection or Vaccination Are Associated With High Re-Infection Rates in Haemodialysis and Renal Transplant Patients

Number of pages: 20 Posted: 13 Oct 2021
University of Oxford - Transplantation Research and Immunology Group, University of Oxford, University of Oxford, University of Oxford - Peter Medawar Building for Pathogen Research, The Oxford Vaccine Group, University of Oxford - Oxford Vaccine Group, University of Oxford, University of Oxford, University of Oxford, University of Oxford, University of Oxford, University of Oxford - Peter Medawar Building for Pathogen Research, Newcastle University - Translational and Clinical Research Institute Immunity and Inflammation Theme, Newcastle University, University of Birmingham - Institute of Cancer and Genomic Sciences, University of Sheffield - Department of Infection, Immunity & Cardiovascular Disease, University of Liverpool - NIHR Health Protection Research Unit in Emerging and Zoonotic Infections, University of Oxford, University of Oxford, University of Oxford, University of Oxford - Peter Medawar Building for Pathogen Research, University of Oxford, University of Oxford - Nuffield Department of Surgical Sciences, University of Oxford, University of Oxford and University of Oxford - Nuffield Department of Clinical Medicine
Downloads 71 (443,954)

Abstract:

Loading...

SARS-CoV-2, Haemodialysis, transplant, end-stage renal disease, vaccine, re-infection

9.

Longitudinal Protection Following Natural SARS-CoV-2 Infection and Early Vaccine Responses: Insights from a Cohort of Community Based Dental Health Care Professionals

Number of pages: 15 Posted: 15 Feb 2021
University of Birmingham - Clinical Immunology Service, University of Birmingham - Institute of Cancer and Genomic Sciences, University of Birmingham - Institute of Clinical Sciences, The Binding Site Group Ltd., University of Birmingham - Clinical Immunology Service, University of Birmingham - Clinical Immunology Service, University of Birmingham - Clinical Immunology Service, University of Birmingham - Clinical Immunology Service, Birmingham Local Dental Committee, Birmingham Community Healthcare Trust, Birmingham Community Healthcare Trust, Birmingham Community Healthcare Trust, Birmingham Community Healthcare Trust, Birmingham Community Healthcare Trust, Birmingham Community Healthcare Trust, University of Birmingham - Clinical Immunology Service, University of Birmingham - Institute of Cancer and Genomic Sciences, Birmingham Community Healthcare Trust and Birmingham Community Healthcare Trust
Downloads 59 (487,367)

Abstract:

Loading...

Dentistry, SARS-CoV-2. COVID-19, vaccination, antibodies

10.

Determinants of Antibody Responses to Two Doses of ChAdOx1 nCoV-19 or Bnt162b2 and a Subsequent Booster Dose of BNT162b2 or mRNA-1273: Population-Based Cohort Study (COVIDENCE UK)

Number of pages: 36 Posted: 03 Mar 2022
Queen Mary University of London, University of Birmingham - Institute of Cancer and Genomic Sciences, Queen Mary University of London - Institute of Population Health Sciences, Queen Mary University of London, Queen Mary University of London, Queen Mary University of London - Institute of Population Health Sciences, Queen Mary University of London, Queen Mary University of London, Queen Mary University of London, Jane Symons Media, Swansea University - Swansea University Medical School, Swansea University - Population Data Science, Queen Mary University of London - Institute of Population Health Sciences, Queen's University Belfast, University of Edinburgh - Asthma UK Centre for Applied Research, Queen Mary University of London - Institute of Population Health Sciences, University of Birmingham - Institute of Cancer and Genomic Sciences and Queen Mary University of London - Barts and The London School of Medicine and Dentistry
Downloads 43 (557,574)

Abstract:

Loading...

SARS-CoV-2 vaccine, ChAdOx1, BNT162b2, mRNA-1273, antibody, ethnicity, obesity, vitamin D

11.

A Prospective Diagnostic Study to Measure the Accuracy of Detection of SARS-CoV-2 Variants Of Concern (VOC) Utilising a Novel RT-PCR GENotyping Algorithm in an in silico Evaluation (VOC-GENIE)

Number of pages: 17 Posted: 08 May 2021
Novacyt Group, Novacyt Group, University of Birmingham - Institute of Cancer and Genomic Sciences, Hampshire Hospitals NHS Foundation Trust - Basingstoke and North Hants Hospital, Microbiology Department, Hampshire Hospitals NHS Foundation Trust - Basingstoke and North Hants Hospital, Microbiology Department, Hampshire Hospitals NHS Foundation Trust - Basingstoke and North Hants Hospital, Microbiology Department, Hampshire Hospitals NHS Foundation Trust - Basingstoke and North Hants Hospital, Microbiology Department, Royal Infirmary of Edinburgh - Department of Medical Microbiology, Novacyt Group, Novacyt Group, Novacyt Group, Novacyt Group and Queen Mary University of London
Downloads 41 (567,699)

Abstract:

Loading...

12.

Determinants of Pre-Vaccination Antibody Responses to SARS-CoV-2: A Population-Based Longitudinal Study (COVIDENCE UK)

Number of pages: 31 Posted: 18 Oct 2021
Queen Mary University of London - Institute of Population Health Sciences, University of Birmingham - Institute of Cancer and Genomic Sciences, Queen Mary University of London - Institute of Population Health Sciences, Queen Mary University of London, Queen Mary University of London, Queen Mary University of London, Queen Mary University of London, Queen Mary University of London, Jane Symons Media, Swansea University - Swansea University Medical School, Swansea University - Population Data Science, Queen Mary University of London - Institute of Population Health Sciences, Queen's University Belfast, University of Edinburgh - Asthma UK Centre for Applied Research, University of Birmingham - Institute of Cancer and Genomic Sciences, Queen Mary University of London - Institute of Population Health Sciences and Queen Mary University of London - Barts and The London School of Medicine and Dentistry
Downloads 31 (623,745)

Abstract:

Loading...

SARS-CoV-2, anti-S IgG IgA IgM, alcohol, physical exercise, ethnicity, obesity, travel, occupation

The Innate and Adaptive Immune Landscape of SARS-CoV-2-Associated Multisystem Inflammatory Syndrome in Children (MIS-C) from Acute Disease to Recovery

Number of pages: 48 Posted: 16 Apr 2021
University of Birmingham - Institute of Immunology and Immunotherapy, University of Limerick - Health Research Institute and the Bernal Institute, University of Birmingham - Institute of Cancer and Genomic Sciences, University of Warwick - Division of Biomedical Sciences, University of Warwick - Bioinformatics Research Technology Platform, University of Warwick - Division of Biomedical Sciences, University of Birmingham - Institute of Immunology and Immunotherapy, Birmingham Women’s and Children’s NHS Foundation Trust, Government of the United Kingdom - Birmingham Women’s and Children’s NHS Foundation Trust, Government of the United Kingdom - Birmingham Women’s and Children’s NHS Foundation Trust, University Hospitals Birmingham NHS Foundation Trust, Government of the United Kingdom - Birmingham Women’s and Children’s NHS Foundation Trust, Birmingham Women’s and Children’s NHS Foundation Trust - Paediatric Intensive Care Unit, Government of the United Kingdom - Birmingham Women’s and Children’s NHS Foundation Trust, Government of the United Kingdom - Birmingham Women’s and Children’s NHS Foundation Trust, Birmingham Women’s and Children’s NHS Foundation Trust - Paediatric Intensive Care Unit, University Hospitals Birmingham NHS Foundation Trust - Heartlands Hospital, University of Birmingham, University of Birmingham - Institute of Cancer and Genomic Sciences, University of Birmingham - NIHR Birmingham Biomedical Research Centre and Institute of Cancer and Genomic Sciences and University of Birmingham - Institute of Immunology and Immunotherapy
Downloads 7 (852,572)

Abstract:

Loading...

The Innate and Adaptive Immune Landscape of SARS-CoV-2-Associated Multisystem Inflammatory Syndrome in Children (MIS-C) From Acute Disease to Recovery

Number of pages: 55 Posted: 19 Jul 2021
University of Birmingham - Institute of Immunology and Immunotherapy, University of Limerick - Health Research Institute and the Bernal Institute, University of Birmingham - Institute of Cancer and Genomic Sciences, University of Warwick - Division of Biomedical Sciences, University of Warwick - Bioinformatics Research Technology Platform, University of Warwick - Division of Biomedical Sciences, University of Limerick - Health Research Institute and the Bernal Institute, Birmingham Women’s and Children’s NHS Foundation Trust, Birmingham Women’s and Children’s NHS Foundation Trust, Birmingham Women’s and Children’s NHS Foundation Trust, University Hospitals Birmingham NHS Foundation Trust - Heartlands Hospital, Birmingham Women’s and Children’s NHS Foundation Trust, Birmingham Women’s and Children’s NHS Foundation Trust - Paediatric Intensive Care Unit, Birmingham Women’s and Children’s NHS Foundation Trust, Birmingham Women’s and Children’s NHS Foundation Trust, Birmingham Women’s and Children’s NHS Foundation Trust, University Hospitals Birmingham NHS Foundation Trust - Heartlands Hospital, University of Birmingham - Clinical Immunology Service, University of Birmingham - Institute of Cancer and Genomic Sciences, Cardiff University - Systems Immunity Research Institute, Cardiff University - Systems Immunity Research Institute, University of Birmingham - NIHR Birmingham Biomedical Research Centre and Institute of Cancer and Genomic Sciences and University of Birmingham - Institute of Immunology and Immunotherapy
Downloads 6 (863,621)

Abstract:

Loading...